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Abstract
Heart disease, the leading cause of death in humans, is 
estimated to affect one in four American adults in some 
form. One predominant cause of heart failure in young 
adults is myocarditis, which can lead to the develop-
ment of dilated cardiomyopathy, a major indication for 
heart transplantation. Environmental microbes, includ-
ing viruses, bacteria, and fungi that are otherwise innoc-
uous, have the potential to induce inflammatory heart 
disease. As the list is growing, it is critical to determine 
the mechanisms by which microbes can trigger heart 
autoimmunity and, importantly, to identify their tar-
get antigens. This is especially true as microbes showing 
structural similarities with the cardiac antigens can pre-
dispose to heart autoimmunity by generating cross-re-
active immune responses. In this review, we discuss the 
relevance of molecular mimicry in the mediation of in-
fectious myocarditis.
Keywords: heart, infectious myocarditis, autoimmunity, 
molecular mimicry, coxsackievirus, microbial mimics, 
mimicry epitopes 
Introduction
Heart disease is the leading cause of death in humans 
[1]. An estimated 80 million American adults (one in 
four) have some form of cardiovascular disease [1, 2], 
with a projected incidence of 40.5 % by 2030 [3]. Myo-
carditis is a predominant cause of heart failure in young 
adults [4, 5]. Most individuals affected by myocardi-
tis remain asymptomatic, and the disease spontane-
ously resolves frequently; however, 10–20 % of the pa-
tients with myocarditis—an estimated 20,000 to 40,000 
patients per year in the USA—can develop chronic dis-
ease leading to dilated cardiomyopathy (DCM), with 
an incidence of 3.5 to 8.5 cases per 100,000 population, 
or 9,000 to 20,000 new cases annually [6, 7]. Approxi-
mately half of DCM patients undergo heart transplan-
tation due to lack of available, effective therapeutic op-
tions. The estimated cost of caring for DCM patients is 
$7 billion annually in the USA alone [8, 9]. Two lines 
of evidence exist to suggest that inflammatory infil-
trates can be present in the hearts of healthy individ-
uals to a low degree: (1) Myocarditis is suspected to be 
the cause in 5–22 % of sudden deaths in athletes less 
than 35 years old [4, 10–12] and (2) a necropsy study 
involving more than 12,000 accidental deaths revealed 
the presence of inflammatory infiltrates in the hearts of 
1.06 % of individuals [13]. But what triggers myocardi-
tis in these apparently healthy individuals is a funda-
mental question to be addressed in cardiology research. 
Accumulated literature suggests that the genesis of 
myocarditis requires the mediation of a variety of im-
mune cells of both the innate (natural killer T cells, γδ T 
cells, mast cells) and adaptive immune systems (CD4 T 
cells, CD8 T cells, and B cells) involving multiple mech-
anisms or pathways [2, 14]. In this review, we discuss 
how environmental microbes can cause myocarditis by 
molecular mimicry.
Published in Journal of Cardiovascular Translational Research, doi: 10.1007/s12265-013-9519-3
Copyright © 2013 Springer Science+Business Media, New York. 
Submitted August 15, 2013; accepted November 11, 2013; published online November 22, 2013.
Relevance of Molecular Mimicry in the Mediation  
of Infectious Myocarditis
Chandirasegaran Massilamany,1 Sally A. Huber,2 Madeleine W. Cunningham,3 and Jay Reddy1
1. School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln,  
Room 202, Bldg VBS, Lincoln, NE 68583
2. Department of Pathology, University of Vermont College of Medicine, Colchester, VT
3. Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center,  
Oklahoma City, OK
  
Corresponding author — Jay Reddy, nreddy2@unl.edu
1
digitalcommons.unl.edu
2 M a s s i l a M a n y ,  e t  a l . ,  i n  J o u r n a l  o f  C a r d i o v a s C u l a r  T r a n s l a T i o n a l  r e s e a r C h 
Environmental Microbes in the Causation of 
Myocarditis
Generally, it is believed that microbial infections can 
trigger autoimmune responses in genetically suscepti-
ble individuals. However, unlike other diseases caused 
by known specific etiologies, it is practically difficult to 
prove all of the Koch’s postulates for autoimmune dis-
eases [15]. Furthermore, a theme is now emerging to 
suggest that exposure to multiple microbes, rather than 
a single microbe, may be critical to initiate autoimmune 
diseases [15]. Mechanistically, microbes that primar-
ily infect the target organ can lead to secondary genera-
tion of autoimmune responses by facilitating the release 
of intracellular self-antigens, which are then recognized 
by the immune system as foreign antigens. A variety of 
pathogens like viruses, bacteria, rickettsia, and parasites 
have been implicated in the causation of myocarditis 
(reviewed in reference [2]), but their direct causal links 
remain tenuous clinically, with the challenge being able 
to prove the cause-and-effect relationship.
One mechanism by which microbes can break self-tol-
erance is by inducing cross-reactive immune responses 
through molecular mimicry because of their antigenic 
similarities with host proteins (reviewed in references 
[6, 16]). Cross-reactivity can occur for antibodies and/
or T cells [6, 16, 17]. For antibodies, cross-reactivity has 
been noted for linear sequences containing amino ac-
ids identical to the self-antigens, and also for homolo-
gous, but non-identical sequences, including for epit-
opes, derived from unrelated molecules such as proteins 
and carbohydrates [18]. For T cells however, cross-reac-
tivity occurs as a result of degeneracy in the recognition 
of peptides displayed by major histocompatibility com-
plex (MHC) molecules (Fig. 1). T cell degeneracy can oc-
cur for microbial peptides sharing stretches of amino 
acids significantly identical to self-antigens or even for 
those peptides bearing the minimal sequence identities, 
so long the critical MHC- and T cell receptor (TCR)-con-
tact residues are preserved [19]. While, the autoantibod-
ies produced by B cells can activate complement cascade 
leading to the induction of type II and type III hypersen-
sitivity reactions, the CD4 helper T cells and cytotoxic 
T lymphocytes (CTLs) mediate their effects through the 
production of cytokines and cytolysis, respectively [20].
Association of Autoimmunity in Diseases Caused 
by Common Infectious Pathogens of Cardiovascular 
System
Evidence from Human Studies
In at least four examples, autoimmunity can be an im-
portant component of cardiovascular diseases caused 
by infectious agents: coxsackievirus B (CVB)3 in post-
infectious myocarditis [21], Trypanosoma cruzi in Cha-
gas heart disease [22], Chlamydia in myocarditis and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
coronary artery disease [23, 24], and β-hemolytic strep-
tococci in rheumatic heart disease (RHD) [25–28].
Coxsackieviruses are generally implicated as causes of 
myocarditis in North America [29]. In the USA, approx-
imately five million enterovirus infections are attributed 
to CVB1–5, and 12 % of those may have myocardial in-
volvement, in which CVB1, CVB3, and CVB5 serotypes 
are commonly implicated [30, 31]. Serologically, CVB3-
reactive antibodies are found in about 50 % of DCM pa-
tients, while enterovirus genomic material can be de-
tected in up to 70 % [32–34], suggesting CVB3-mediated 
autoimmunity can play a role in myocarditis/DCM 
pathogenesis. Isolation of infectious CVB particles is not 
commonly reported in patients with myocarditis/DCM 
as the myocardial biopsies are taken mostly in rare cases 
[35]. But, when isolated for example at necropsy, the viral 
isolates were found to be pathogenic in mice [36].
Chagas heart disease caused by T. cruzi is the leading 
cause of infectious myocarditis in the world [37]. Autoim-
munity is suspected in the disease pathology, and autore-
Figure 1. Mechanistic basis for TCR degeneracy. αβ TCR-expressing 
CD4 T cells recognize peptide fragments presented in the context of 
class II MHC molecules by antigen-presenting cells. The side chains 
of some amino acids in the peptide sequence are extended. Such res-
idues preferentially anchor MHC molecules, which are commonly 
referred as MHC-anchor residues (bottom arrows: solid, primary; 
dotted, secondary). Similarly, side chains of solvent-exposed resi-
dues also can interact with TCRs, and they are called TCR contact 
residues (top arrows: solid, primary; dotted, secondary). Substitu-
tions, if any, in the primary positions can lead to complete ablation 
of the T cell response, but similar substitutions are tolerable for sec-
ondary TCR contact residues [90]. Such precise recognition has been 
demonstrated in the case of the hemoglobin (Hb) molecule, where a 
single amino acid substitution at the primary TCR contact site (glu-
tamic acid 73) in Hb 64–76 resulted in 1,000-fold weaker recognition 
by the T cells [90]. Such an event can occur for two entirely differ-
ent ligands, if the primary T cell contact residue alone is preserved 
in both. For example, in the transgenic mouse model of spontaneous 
rheumatoid arthritis, a TCR specific for bovine ribonuclease 42–56 
can recognize another irrelevant ligand, glucose-6-phosphate isom-
erase 281–293, which is a self-peptide [90]. Thus, enormous poten-
tial exists for microbes that bear the sequences of self-antigens to 
induce cross-reactive T cell responses, as long as the critical MHC- 
and TCR-interacting residues are preserved.
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activity appears to reside in the CD4 T cell compartment, 
although CD8 T cells outnumber CD4 T cells in heart in-
filtrates (3:1) [38, 39]. By deriving T cell clones and anti-
bodies from patients with Chagas disease, reactivities 
were observed for various cardiac proteins including car-
diac myosin, and also for antigenic epitopes from T. cruzi 
proteins such as B13, cysteine protease cruzipain, and ri-
bosomal proteins P1 and P2. But their disease-inducing 
potential remains to be tested experimentally [38, 40, 41].
Chlamydial myocarditis characterized by subclinical 
or asymptomatic phenotype has been noted in 5–15 % of 
the individuals’ positive for Chlamydia psittaci infection. 
Likewise, two other chlamydial species are also impli-
cated in the causation of myocarditis, namely Chlamydia 
pneumoniae and Chlamydia trachomatis, where C. pneu-
moniae appears to induce more severe disease than C. 
trachomatis [42, 43]. The underlying autoimmune mecha-
nisms in chlamydial infections, if any, are unknown.
In group A streptococcal infections, the concept 
of molecular mimicry has been implicated as a major 
mechanism of disease pathogenesis. Antibodies and 
T cells specific to streptococcal M protein have been 
shown to cross-react with host protein, cardiac myo-
sin, and M protein [26, 27]. A cytotoxic human monoclo-
nal antibody against the group A carbohydrate epitope 
N-acetyl-β-d-glucosamine generated from rheumatic 
carditis patient has delineated the sharing of epitopes 
between the group A streptococcus, cardiac myosin, 
and the valve endothelium, basement membrane, and 
laminin [44]. The basis of this mimicry is the alpha he-
lical structures of the shared molecules [45]. Also, pep-
tide epitopes of human cardiac myosin have been iden-
tified in RHD [46]. Antibodies in rheumatic carditis are 
believed to damage the valve endothelium in human 
disease leading to edema of the valve and activation of 
the endocardium and T cell infiltration in the valve [47]. 
Thus, mimicry is believed to play a role in attacking the 
heart valve through both antibodies and T cells in hu-
man rheumatic carditis. Furthermore, T cell clones de-
rived from intralesional fragments from patients with 
RHD react with three different regions within the strep-
tococcal protein M5, as well as cardiac proteins derived 
from valvular tissue, and the immunodominant epitope 
of M5 protein has been localized to a region spanning 
the amino acids 81–103 [48–50]. Similarly, T cell clones 
recognizing other peptide regions of M5, namely B2 and 
B3A, can react with S2 and light meromyosin regions 
of human cardiac myosin, suggesting that the immune 
pathogenesis of RHD involves the mediation of cross-re-
active T cell responses potentially for a broad spectrum 
of cardiac antigens [18, 27, 48, 50].
Interestingly, molecular mimicry has not been lim-
ited to cross-reactivity between host and pathogen, 
but has been extended to include antibodies generated 
against one host antigen (cardiac myosin or its peptide 
fragment S2-16 from the S2 hinge region) which can 
cross-react with another host antigen, β-adrenergic re-
ceptor-1 (BAR), possibly leading to apoptosis of cardio-
myocytes via the cyclic adenosine monophosphate-de-
pendent protein kinase A signaling pathway [51, 52]. 
Such an effect by antibodies which signal receptors on 
cardiomyocytes could be blocked by human cardiac my-
osin and β-adrenergic blocker [51]. Likewise, cardiac ad-
enine nucleotide translocator 1 (ANT) and anti-CVB3 
antibodies can cross-react with each other, suggesting a 
role for ANT autoantibodies in CVB3/DCM pathogen-
esis [53], possibly by altering the functional activities of 
ANT (e.g., energy metabolism) [54, 55]. Thus, antibod-
ies which affect the physiology and function of the heart 
may be important in leading to altered heart function 
and arrhythmias in cardiomyopathy.
Evidence from Animal Models
Animal models are useful tools to delineate the auto-
immune events in various diseases caused by infec-
tious pathogens. One such model is experimental au-
toimmune myocarditis (EAM), and the EAM models 
are valuable because their histological features bear re-
semblance to post-infectious myocarditis induced with 
pathogens like CVB3 [56, 57]. The disease is induced in 
susceptible strains of rodents by immunizing the an-
imals with cardiac proteins, such as cardiac myosin 
heavy chain-α (Myhc-α), and cardiac troponin I or their 
peptide fragments [58–60]. The immune pathogenesis of 
EAM is typically described as delayed-type hypersen-
sitivity reaction that involves the mediation of T cells 
and macrophages. Although Myhc-α is located intra-
cellularly, its peptide fragments have been found to be 
displayed by antigen-presenting cells in several mouse 
strains (C.B-17, SCID, B10.D2, DBA/2J, and A/J) lead-
ing to the recognition of myosin peptides by T cells [58, 
61]. Using Myhc-α 334–352 as a putative antigen, we re-
cently attempted to identify the microbes that have the 
potential to trigger myocardial injuries by molecular 
mimicry. We identified three novel microbial agents—
Cryptococcus neoformans, Bacillus spp. (BAC), and Mag-
netospirillum gryphiswaldense—that carry the mimicry se-
quence for Myhc-α 334–352 [62]. The mimicry epitopes 
induce lymphocytic myocarditis in A/J mice reminis-
cent of the disease induced with Myhc-α 334–352, indi-
cating that exposure to these microbes might predispose 
to heart autoimmunity [62].
CVB3 is one of the bona fide pathogens of cardiovas-
cular system being used in the myocarditis research. In-
fection studies with CVB3 in mice have shown that the 
disease course exhibit two distinct stages that occur in 
continuum similar to the biphasic nature of the disease 
in humans [63, 64]: the acute phase (14–18 days postin-
fection), in which infectious virus is present causing 
damage to cardiac myocytes, and the chronic phase (be-
yond 18 days postinfection), in which inflammation re-
appears, although the extent of virus replication is much 
reduced due to selection of a defective virus [56, 65]. 
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Previously, it was shown that the severity of CVB3-in-
duced myocarditis was relatively high in mice deficient 
for CD8, but the disease was attenuated in mice defi-
cient for CD4. Conversely, the mice deficient for both 
CD8 and CD4 were better protected, suggesting that 
both cell types modulate the disease outcome [66]. Evi-
dence of autoimmunity in CVB3 infection was first pro-
vided based on the observation that the CTLs gener-
ated in Balb/C mice infected with CVB3 were lytic to 
cardiomyocytes, and the CTLs were capable of induc-
ing the disease in naïve mice, but their antigen-specific-
ity was unknown [67, 68]. Using MHC class II/IAk dex-
tramers for Myhc-α 334–352, we recently showed that 
the post-infectious myocarditis induced with CVB3 in 
A/J mice is accompanied by the generation of patho-
genic cardiac myosin-specific CD4 T cells that can trans-
fer disease into naïve recipients [69]. We are currently 
investigating whether CVB3 infection also can lead to 
the generation of T cells that react with other cardiac 
antigens, and if so, whether these are pathogenic. Such 
a possibility exists because CVB3 infection is accom-
panied by the generation of antibodies for several car-
diac antigens [70, 71]. Whether molecular mimicry hy-
pothesis is relevant to CVB3 pathogenesis continues to 
be uncertain as there are no significant sequence iden-
tities between CVB3 proteome and a well-characterized 
cardiac antigen, Myhc-α. But, the recent data suggest 
that CVB3 infection can possibly lead to the generation 
of cross-reactive antibodies for actin because certain de-
gree of sequence homology exists between the two [72]. 
Likewise, whether the virus that can persist in defective 
form [65], reactivates, and aggravates disease as a result 
of viral damage of cardiac tissue is unknown.
In experimental Chagas heart disease, immuniza-
tion of mice with T. cruzi proteins led to the induction of 
cross-reactive immune responses to cardiac myosin [73]. 
Likewise, the animals immunized with cardiac myosin 
also showed parasite-reactive immune response [38, 74]. 
Consistent with these observations, tolerance studies also 
suggest that cardiac myosin might be the primary auto-
antigen recognized in Chagas heart disease [73, 74]. Re-
cent data, however, indicate that other antigens such as 
BAR and muscarinic cholinergic (MC) receptors also may 
be targeted in the progression of Chagas heart disease as 
autoantibodies generated against BAR and MC receptors 
reacted with T. cruzi ribosomal proteins [75, 76].
As to the chlamydial infections, peptides from cyste-
ine-rich outer membrane protein—C. trachomatis serovar 
E (ChTR1) 25–40; C. trachomatis serovar C (ChTR2) 25–
40; C. trachomatis serovars L1, L2, and L3 (ChTR3) 25–
40; C. pneumoniae (ChPN) 25–40; and C. psittaci (ChPS) 
25–40—were found to share sequence identities with 
Myhc-α [23]. By active immunization, the mimicry epi-
topes induced comparable myocarditis in mice accom-
panied with the generation of cross-reactive T cells and 
antibodies [23, 77]. However, in infection studies, al-
though animals infected with Chlamydia showed myo-
carditis and heart-specific antibodies [23, 78], it was not 
clear whether the antibodies were produced secondarily 
as a result of recognition of cardiac antigens released 
following bacterial damage to the heart tissue or as a 
consequence of molecular mimicry. Regardless of their 
mechanisms however, the disease-inducing abilities 
of cardiac antibodies produced in the infected animals 
has not been tested in the adoptive transfer protocols. 
Likewise, whether the animals infected with chlamydia 
show the generation of pathogenic cardiac-reactive T 
cells also has not been investigated. This is a fundamen-
tal question to be addressed because T cell help is crit-
ical for production of antibodies. Thus, whether auto-
immune response contributes to the pathogenesis of 
chlamydial myocarditis continues to be debated.
The relevance of molecular mimicry in the pathogen-
esis of RHD induced by streptococci has been well-stud-
ied in various rodent models. Antibodies against the 
group A streptococcal carbohydrate epitope, N-acetyl-
β-d-glucosamine, have been shown to recognize alpha 
helical sequences [45, 79, 80] and represent mimicry be-
tween two dissimilar structures. Anti-group A strepto-
coccal antibodies can also cross-react with both CVB3 
and cardiac myosin [81, 82]. These cross-reactive im-
mune responses were shown to be pathogenic in the 
mouse model of CVB3 infection [83]. Mouse monoclo-
nal antibodies that recognize the motif QKSKQ within 
the streptococcal proteins M5 and M6 can react pre-
dominantly with Myhc-α [84], and other proteins, such 
as tropomyosin, laminin, vimentin, and keratin, may 
play a role in group A streptococcal cross-reactivities 
with heart and other tissues [44, 45, 79, 81, 85–87]. Stud-
ies in mice suggested that T cells against streptococcal 
M proteins are pathogenic and have been shown to re-
act with the myocarditogenic peptide NT4 from strep-
tococcal M5 protein which can cross-react with cardiac 
myosin and CVB3 [83], and the severity of viral myo-
carditis is reduced in mice tolerized with NT4 peptide 
[25, 83]. Similarly, streptococcal M protein and/or cer-
tain M protein peptides were shown to induce valvulitis 
in rats [88] and myocarditis in mice [83, 89]. Molecular 
mimicry although is thought of as a disease process can 
also be part of the normal immune response to protect 
against pathogens, as the mechanism dictates “survival 
of the fittest.” For example, an antibody recognizing 
both host and multiple microbial ligands can be thought 
of as “killing two birds with one stone” as the host pro-
tects itself using an antibody which neutralizes multi-
ple pathogens. Studies have demonstrated this principle 
when mouse monoclonal antibodies generated against 
the group A streptococcus also neutralized CVB3 and 
were cytotoxic for heart cells [81].
Conclusion
The general belief is that environmental microbes, 
mostly viruses, can trigger autoimmune diseases in ge-
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netically susceptible individuals; the challenge is be-
ing able to establish their cause and effect relationship. 
More recent data suggest that exposure to environmen-
tal microbes of non-viral origin carrying the sequences 
identical to Myhc-α, which are otherwise innocuous 
like BAC, has the potential to trigger heart autoimmu-
nity through molecular mimicry. But a formal proof is 
needed to verify whether such a phenomenon can occur 
in humans. Likewise, whether exposure to multiple mi-
crobes is required to trigger heart autoimmunity also is 
not known. This can be addressed in animal models by 
exposing the myocarditis-susceptible animals to differ-
ent microbes sequentially like CVB3 followed by BAC 
or vice versa. To this end, we are setting up an infection 
model with BAC. Our preliminary data suggest that A/J 
mice infected with BAC show the generation of Myhc-
α-reactive T cells (unpublished observations). Although 
translating the information generated in animal models 
to humans is challenging, the growing list of microbes 
of non-viral origin as potential candidates for heart au-
toimmunity may create opportunities to target them 
therapeutically.
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